What We're Reading: Page 52
Industry reads hand-picked by our editors
Jul 05, 2024
-
The Washington Post
Dengue fever is surging worldwide. The epidemic has reached the U.S.
-
Financial Times
To cure disease, AI needs more of our data
-
Bloomberg
Weight-Loss Drugs Like Wegovy Are Creating Lots of Trash
-
The New York Times
V. Craig Jordan, Who Discovered a Key Breast Cancer Drug, Dies at 76
Jul 03, 2024
-
Endpoints News
Takeda to lay off more employees in Massachusetts
-
ApexOnco
Gilead’s multiple bets on fast Car production
-
Boston Business Journal
Vertex to stay at Fan Pier HQ
Jul 02, 2024
Jul 01, 2024
-
Science News
Supreme Court ruling may threaten role of science in U.S. rulemaking
-
Fierce Pharma
Pfizer poaches Novartis exec as oncology commercial chief
-
Financial Times
Swiss buyout firm Partners Group lands deal for stake in €900mn biotech firm
-
Axios
“New era” of cosmetics’ regulation: FDA wields new powers over makeup companies
Jun 28, 2024
-
NPR
Health insurers cover fewer drugs and make them harder to get
-
Associated Press
As COVID-19 ticks up in some places, US health officials recommend a fall vaccination campaign
-
Reuters
Drugmaker Servier loses EU court fight over pay-for-delay deals
-
To cure disease, AI needs more of our data
Jun 27, 2024
-
AP News
The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue Pharma
-
Reuters
US FDA approves Verona Pharma’s inhaled COPD therapy
-
Hunterbrook Media
Hims & Hers Selling GLP-1 Injection That’s Not FDA Approved, From Shady Supplier — And Won’t Make You Talk to a Doctor to Get It
Previous
